[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340417-105":59,"doc-detail-340417-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","relative-burden-of-cancer-and-noncancer-mortality-among-long-term-survivors-of-differentiated-thyroid-cancer-in-the-us","Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US","","Relative risks of cancer-specific and noncancer-specific mortality among long-term survivors with differentiated thyroid cancer remain insufficiently characterized. A retrospective nationwide analysis used SEER data (1992–2020) and applied an accelerated failure time framework to estimate survival time ratios, with competing-risks modeling for patients surviving at least 5 years. Results show noncancer-specific mortality consistently exceeding DTC-specific mortality across age and gender, with stage-dependent risk escalation. Postoperative follow-up should emphasize noncancer mortality for stages I–II and DTC-related causes for stages III–IV.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/relative-burden-of-cancer-and-noncancer-mortality-among-long-term-survivors-of-differentiated-thyroid-cancer-in-the-us/340417/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/relative-burden-of-cancer-and-noncancer-mortality-among-long-term-survivors-of-differentiated-thyroid-cancer-in-the-us/340417.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study evaluate about long-term differentiated thyroid cancer survivors?","Question",{"text":113,"@type":114},"The study compares the relative burden of cancer-specific mortality and noncancer-specific mortality among long-term differentiated thyroid cancer survivors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which data source and statistical approach were used?",{"text":118,"@type":114},"Nationwide SEER data from 1992–2020 were analyzed using an accelerated failure time model for survival time ratios, and competing-risks modeling to assess relative risks of outcomes for patients surviving at least 5 years.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key findings regarding noncancer vs DTC mortality?",{"text":122,"@type":114},"Noncancer-specific mortality rates were consistently higher than DTC-specific mortality rates across age groups and genders, and risks varied according to TNM stage with greater risk at advanced stages.",{"name":124,"@type":111,"acceptedAnswer":125},"How should follow-up attention differ by disease stage?",{"text":126,"@type":114},"For stage I–II patients, postoperative follow-ups should focus more on noncancer-specific mortality, whereas for stage III–IV patients greater consideration should be given to DTC-related causes of death.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},340417,1790120157,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 25 October 2024 DOI 10.3389/fendo.2024.1425634  \nOPEN ACCESS  \nEDITED BY  \nPaula Soares,  \nUniversity of Porto, Portugal  \nREVIEWED BY  \nGeorge Simeakis,  \n401 General Military Hospital of Athens, Greece  \nHao Zhao,  \nCapital Medical University, China  \n*CORRESPONDENCE  \nWenwu Dong  \n [dongwenwu@cmu.edu.cn](dongwenwu@cmu.edu.cn)[ ](dongwenwu@cmu.edu.cn)Ping Zhang  \n [zhangping@cmu.edu.cn](zhangping@cmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 30 April 2024  \nACCEPTED 10 October 2024  \nPUBLISHED 25 October 2024  \nCITATION  \nShi Y, Lv C, Liu P, Zheng Y, Zhang H, Dong W and Zhang P (2024) Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US. Front. Endocrinol. 15:1425634 .  \ndoi: 10.3389/fendo.2024.1425634  \nCOPYRIGHT  \n© 2024 Shi, Lv, Liu, Zheng, Zhang, Dong and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRelative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid  \ncancer in the US  \nYang Shi †, Chengzhou Lv †, Pai Liu †, Yuenan Zheng, Hao Zhang, Wenwu Dong*† and Ping Zhang*†  \nDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China  \nBackground: Limited information is available regarding the relative risks of cancer-speciﬁc mortality and noncancer-speciﬁc mortality among long-term survivors with differentiated thyroid cancer (DTC) .  \nMethods: In this retrospective study, nationwide data from the Surveillance, Epidemiology, and End Results database (1992-2020) were utilized. The Accelerated Failure Time Model was applied to calculate Survival Time Ratios (TR), with the primary focus on mortality resulting from DTC. The competing risks model was employed to investigate the relative risks of various outcomes in DTC patients with a survival duration of 5 years or more.  \nResults: In our cohort, 279 patients succumbed to DTC, while 748 died from other diseases. Notably, in DTC cohorts, noncancer-speciﬁc mortality rates were consistently higher than DTC-speciﬁc mortality rates across different age groups and genders. The risk of DTC and noncancer-speciﬁc mortality varied based on the TNM stage. With more advanced disease stages, the risk of DTC and other cancer-speciﬁc mortality gradually increased. The cumulative mortality from other cancer-speciﬁc causes was consistently the lowest.  \nConclusions: In long-term surviving DTC patients, noncancer-speciﬁc mortality outweighed DTC-speciﬁc mortality irrespective of age and gender. For stage I and II patients, increased attention should be directed toward noncancerspeciﬁc mortality in postoperative follow-ups. Conversely, for stage III and IV patients, greater consideration should be given to DTC-related causes of death. In addition, for stage III and IV DTC patients, the risk of death from other cancers was signiﬁcantly higher than for stages I and II.  \nKEYWORDS  \ndifferentiated thyroid cancer, prognosis, competing risks model, DTC, SEER  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nThyroid cancer stands as the most prevalent endocrine malignancy, with differentiated thyroid cancer (DTC) comprising around 90% of thyroid cancer (1). According to the 2023 Cancer Data Statistics (2), thyroid cancer is the 7th most common cancer in women (3%) . Enhanced prognosis resulting from early detection and treatment has led to a noteworthy 5-year disease-speciﬁcsurvival rate of 98% for thyroid cancer patient (3) . As a result, an increasing num","cbCaihwh1JkUlPse","https://ap.wps.com/l/cbCaihwh1JkUlPse","pdf",2664534,"English","# Introduction\n# Materials and methods\n# Results\n# Conclusions","[{\"question\":\"What does the study evaluate about long-term differentiated thyroid cancer survivors?\",\"answer\":\"The study compares the relative burden of cancer-specific mortality and noncancer-specific mortality among long-term differentiated thyroid cancer survivors.\"},{\"question\":\"Which data source and statistical approach were used?\",\"answer\":\"Nationwide SEER data from 1992–2020 were analyzed using an accelerated failure time model for survival time ratios, and competing-risks modeling to assess relative risks of outcomes for patients surviving at least 5 years.\"},{\"question\":\"What were the key findings regarding noncancer vs DTC mortality?\",\"answer\":\"Noncancer-specific mortality rates were consistently higher than DTC-specific mortality rates across age groups and genders, and risks varied according to TNM stage with greater risk at advanced stages.\"},{\"question\":\"How should follow-up attention differ by disease stage?\",\"answer\":\"For stage I–II patients, postoperative follow-ups should focus more on noncancer-specific mortality, whereas for stage III–IV patients greater consideration should be given to DTC-related causes of death.\"}]","Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US | PDF",1790036386,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd5ed32020a9db41adbe5d05c75fae50.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/032c5f3e6ac525e8d00614865d9f524a.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c40005ccebe7e4d795a4cb5eb5a66ef4.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/936b0208b574cacc94bab7f6538e03ff.webp",980,1385]